BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 10:13:33 AM | Browse: 1372 | Download: 1408
|
Received |
|
2016-07-31 12:52 |
|
Peer-Review Started |
|
2016-08-01 22:00 |
|
To Make the First Decision |
|
2016-10-20 08:40 |
|
Return for Revision |
|
2016-10-20 14:37 |
|
Revised |
|
2016-11-07 13:23 |
|
Second Decision |
|
2017-03-07 15:26 |
|
Accepted by Journal Editor-in-Chief |
|
2017-03-07 17:34 |
|
Accepted by Executive Editor-in-Chief |
|
2017-03-17 14:01 |
|
Articles in Press |
|
2017-03-17 14:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-09 14:33 |
|
Publish the Manuscript Online |
|
2017-05-15 10:13 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Minireviews |
Article Title |
Effects of glycaemic management on diabetic kidney disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Richard J MacIsaac, George Jerums and Elif I Ekinci |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
ADS-Sevier Research Grant to MacIsaac RJ |
|
|
Corresponding Author |
Richard J MacIsaac, Professor, BSc(HONS), PhD, MBBS, FRACP, Director, Department of Endocrinology and Diabetes, St Vincent’s Health, PO Box 2900, Fitzroy, Melbourne, Victoria 3065,
Australia. r.macisaac@unimelb.edu.au |
Key Words |
Diabetic nephropathy; Albuminuria; Glucose control; Glomerular filtration rate; Diabetes; Chronic kidney disease; Empagliflozin; Liraglutide; Semaglutide |
Core Tip |
Tight glucose control has been clearly shown to reduce the incidence of micro- and macroalbuminuria. Evidence is now also emerging to suggest that intensive glucose control can slow glomerular filtration rate loss and possibly progression to end stage kidney disease. Furthermore, empagliflozin which is a glucose lowering agent of the sodium glucose like transporter-2 inhibitor class has been shown to have reno-protective effects over and above those expected from its glucose lowering effects alone. Recent clinical trials have also shown that Liraglutide and Semaglutide, injectable glucose lowering agents which are analogues of human glucagon like peptide-1, reduce progression to macroalbuminuria. |
Publish Date |
2017-05-15 10:13 |
Citation |
MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017; 8(5): 172-186 |
URL |
http://www.wjgnet.com/1948-9358/full/v8/i5/172 |
DOI |
http://dx.doi.org/10.4239/wjd.v8.i5.172 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345